BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression

Autor: Francina Fonseca, Joan Ignasi Mestre-Pinto, Rocío Rodríguez-Minguela, Esther Papaseit, Clara Pérez-Mañá, Klaus Langohr, Margherita Barbuti, Magí Farré, Marta Torrens, NEURODEP GROUP

Publikováno v: Frontiers in Psychiatry, Vol 13 (2022)

BackgroundMajor depressive disorder (MDD) and cocaine use disorder (CUD) are related with disability and high mortality rates. The assessment and treatment of psychiatric comorbidity is challenging due to its high prevalence and its clinical severity

Externí odkaz: https://doaj.org/article/14f2ec726fe046e7b886a9a9b99e15b4

BDNF and cortisol in the diagnosis of cocaine-induced depression

Autor: Fonseca Casals, Francina, 1972, Mestre-Pintó, Juan Ignacio, Rodríguez-Minguela, Rocío, Papaseit Fontanet, Esther, Pérez Mañá, Clara, Langohr, Klaus, Barbuti, Margherita, Farré Albaladejo, Magí, Torrens, Marta, Neurodep Group

Publikováno v: Frontiers in Psychiatry
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

Background: Major depressive disorder (MDD) and cocaine use disorder (CUD) are related with disability and high mortality rates. The assessment and treatment of psychiatric comorbidity is challenging due to its high prevalence and its clinical severi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eafe54bf89ecbbfd8866db17d696d37c
http://hdl.handle.net/10230/54115

The Tryptophan System in Cocaine-Induced Depression

Autor: Francina Fonseca, Joan-Ignasi Mestre-Pintó, Àlex Gómez-Gómez, Diana Martinez-Sanvisens, Rocío Rodríguez-Minguela, Esther Papaseit, Clara Pérez-Mañá, Klaus Langohr, Olga Valverde, Óscar J. Pozo, Magí Farré, Marta Torrens, on behalf of NEURODEP GROUP

Publikováno v: Journal of Clinical Medicine, Vol 9, Iss 4103, p 4103 (2020)
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Journal of Clinical Medicine
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Journal of Clinical Medicine; Volume 9; Issue 12; Pages: 4103

Major depression disorder (MDD) is the most prevalent psychiatric comorbid condition in cocaine use disorder (CUD). The comorbid MDD might be primary-MDD (CUD-primary-MDD) or cocaine-induced MDD (CUD-induced-MDD), and their accurate diagnoses and tre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4539f6045ae64e22625a6b3bae8a0538
https://www.mdpi.com/2077-0383/9/12/4103

The Tryptophan System in Cocaine-Induced Depression.

Autor: Fonseca F; Addiction Research Group (GRAd), Neuroscience Research Program, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.; Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, 08003 Barcelona, Spain.; Department of Psychiatry and Department of Pharmacology, School of Medicine, Universitat Autònoma de Barcelona (UAB), 08290 Cerdanyola del Vallès, Spain., Mestre-Pintó JI; Addiction Research Group (GRAd), Neuroscience Research Program, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.; Department of Experimental and Health Sciences (CEXS), Universitat Pompeu Fabra, 08002 Barcelona, Spain., Gómez-Gómez À; Department of Experimental and Health Sciences (CEXS), Universitat Pompeu Fabra, 08002 Barcelona, Spain.; Integrative Pharmacology and Systems Neuroscience Research Group, Neuroscience Research Programme, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain., Martinez-Sanvisens D; Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, 08003 Barcelona, Spain., Rodríguez-Minguela R; Addiction Research Group (GRAd), Neuroscience Research Program, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain., Papaseit E; Department of Psychiatry and Department of Pharmacology, School of Medicine, Universitat Autònoma de Barcelona (UAB), 08290 Cerdanyola del Vallès, Spain.; Clinical Pharmacology Department, Hospital Universitari Germans Trias i Pujol (IGTP), 08003 Badalona, Spain., Pérez-Mañá C; Department of Psychiatry and Department of Pharmacology, School of Medicine, Universitat Autònoma de Barcelona (UAB), 08290 Cerdanyola del Vallès, Spain.; Clinical Pharmacology Department, Hospital Universitari Germans Trias i Pujol (IGTP), 08003 Badalona, Spain., Langohr K; Integrative Pharmacology and Systems Neuroscience Research Group, Neuroscience Research Programme, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.; Department of Statistics and Operations Research, Universitat Politècnica de Barcelona Barcelonatech, 08034 Barcelona, Spain., Valverde O; Neurobiology of Behaviour Research Group (GReNeC-NeuroBio), Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08002 Barcelona, Spain.; Neurobiology of Behaviour Research Group, Neuroscience Research Programme, Hospital del Mar Research Institute (IMIM), 08003 Barcelona, Spain., Pozo ÓJ; Integrative Pharmacology and Systems Neuroscience Research Group, Neuroscience Research Programme, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain., Farré M; Department of Psychiatry and Department of Pharmacology, School of Medicine, Universitat Autònoma de Barcelona (UAB), 08290 Cerdanyola del Vallès, Spain.; Clinical Pharmacology Department, Hospital Universitari Germans Trias i Pujol (IGTP), 08003 Badalona, Spain., Torrens M; Addiction Research Group (GRAd), Neuroscience Research Program, Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain.; Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, 08003 Barcelona, Spain.; Department of Psychiatry and Department of Pharmacology, School of Medicine, Universitat Autònoma de Barcelona (UAB), 08290 Cerdanyola del Vallès, Spain., On Behalf Of Neurodep Group

Publikováno v: Journal of clinical medicine [J Clin Med] 2020 Dec 19; Vol. 9 (12). Date of Electronic Publication: 2020 Dec 19.